NTRN 24-hour Amplitude 47.4%: Binance Delisting Approaching Triggers Surge in Trading Volume
Bitget Pulse2026/03/31 20:22Volatility Overview
In the past 24 hours, the price of NTRN surged from a low of $0.00194 to a high of $0.002829, with an amplitude of 47.4%. The current price is $0.001971, showing a significant overall retracement. The 24-hour trading volume is approximately $1.4473 million, with a market capitalization of about $1.6491 million. Other data indicates that the total liquidation amount stands at $145,000.
Summary of Reasons for Price Movements
- Binance is set to delist NTRN and seven other tokens at 03:00 (UTC) on April 1, 2026. As the deadline approaches, trading activity has been stimulated, resulting in sharp fluctuations in both trading volume and price.
- The Neutron project has now entered long-term maintenance mode. The DEX and Supervault will switch to withdrawal-only mode starting from April 17. The market remains sensitive in the aftermath of previous announcements.
Market View and Outlook
The CoinGecko community sentiment shows 80% bullish despite delisting and liquidity risks. Recent trading signals on X indicate that some analysts expect a breakout from the descending wedge pattern, targeting $0.006. However, negative funding rate signals suggest potential downside pressure.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is provided for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives
For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.
Crypto prices
More
